SHELTON, CONNECTICUT — Monday, October 16, 2023 — NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal… Read More
At the outset, cancer vaccines were plagued with false starts and modest success at best. But they now represent a promising therapeutic strategy in the immunotherapy of solid tumors.
&ldq… Read More
Find out what's happening now at AACE American Association of Clinical Endocrinology AACE Weekly October 2023 New! — Listen to AACE Podcast E… Read More
Medpace Holdings Inc (MEDP, Financial) has recently seen a daily gain of 15.37%, and a 3-month gain of 5.11%. With an Earnings Per Share (EPS) (EPS) of 8.37, the question arises: is the stoc… Read More
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete… Read More
MADRID — First-line treatment with the RET inhibitor selpercatinib (Retevmo) achieved superior outcomes in both medullary thyroid cancer (MTC) and advanced non-small cell lung canc… Read More
Generic drug manufacturer and distributor SOHM has completed the LOI process to acquire stem cell gene-editing technology ABBIE from CGA Intellectual Holdings Inc.
The company expec… Read More
BOSTON – Efficacy of the the respiratory syncytial virus (RSV) vaccine held strong for at least two RSV seasons in older adults, according to the AReSVi-006 study.
The RSV perfusion… Read More
Dapagliflozin (Farxiga) lowered HbA1c by 1.03 percentage points more than placebo in children and adolescents with type 2 diabetes, while saxagliptin (Onglyza) showed no significant reduct… Read More
A new “real world” study shows that in people with type 2 diabetes, Ozempic (semaglutide) injections improved blood sugar control and weight loss during a study period of up… Read More
HAMBURG, Germany — Giving metformin early on to women with gestational diabetes failed to show a statistically significant benefit for the phase III EMERGE trial’s primary en… Read More